Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
262728293031 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Catasys Launches OnTrak™ Facebook Page

Catasys Health - Monday, January 04, 2010
Check out our new Catasys Health Facebook Recovery Network http://www.facebook.com/stayontrak. Also, don't forget to Like our Facebook Health Care Page.

Social Media Philosophy - Lead the social media revolution in Substance Dependence and Behavioral Health Care, contributing to health and well being for families and friends everywhere.

 » More

Cutting Edge Treatment for Substance Dependence for Health Plans

Catasys Health - Wednesday, December 16, 2009
For every 1 million members in a health plan, approximately $160 million in claims are incurred by members diagnosed with Substance Dependence. Most health plans have realistic cost savings opportunities in the millions of dollars. Our Medical Economics group can demonstrate specific savings opportunities for health plans with respect to both medical and behavioral costs.

The OnTrak program addresses many of the challenges experts highlight within the existing treatment paradigm for substance dependence. Specifically, OnTrak: » More

Changing the Paradigm of Substance Dependent Treatment

Catasys Health - Wednesday, December 02, 2009

How OnTrak is Different - We function as a provider in your network and your MBHO’s network, complementing your existing delivery system. We go much deeper than your current programs to address the uniquely difficult needs of your high-utilizing substance dependent members. » More


Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 » More
| 1 |

 
 
  Tags
 
meth Harold Urschel alcoholism narcotic placebo-controlled hospitalizations flumazenil addict psychosocial OnTrak opioid abuse opioid Raymond Anton predictive modeling substance dependence depression screening bipolar disorder marijuana percocet SD members medical and behavioral costs stress health insurance anxiety diabetes communication behavioral health care services withdrawal reducing craving medical CIWA UnitedHealthcare prometa Health Care Utilization drug overdose vivitrol opiod abuse urine drug screen substance dependence costs craving score stimulants relapse craving primary care cigarettes sobriety chronic pain fentanyl opiates emergency room relapse prevention ADHD Opioid Treatment data mining smoking Opioid Prescribing recovery network methadone health reform mental health painkillers opioid-drug interactions post-traumatic stress disorder reduction in use alcohol drinking behavioral health prescriptions medical costs mental illness pain medication over-the-counter substances health plan opioid antagonist drug treatment vicodin opiod-based placebo gabapentin behavioral health care randomized buprenorphine Co Occurring Disorders Opioid Medications muscle relaxant drinking opioid overdose contract social network suboxone treatment heroin nicotine pain pills reduction in craving physician- patient relations methamphetamine dependence issues Journal of Psychopharmacology SD health insurance cocaine stratified oxycodone ER substance dependence health insurance OxyContin behavioral healthcare depression care coaching pain killers recovery drug use ADD hydrocodone overdose trauma addiction treatment cocaine treatment naloxone Catasys PTSD binge drinking sober identification facebook sugar Research Across America high-utilizing hospital alcohol dependence drug addicts alcohol treatment drug addiction methamphetamine dependence substance use disorder addiction codeine behavioral healthcare services drug abuse alcohol double-blind morphine
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414